Diabetic Neuropathy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Tuesday, August 8, 2017 Diabetes News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Aug. 7, 2017 /PRNewswire/ --

Global Diabetic Neuropathy Market: OverviewThe report on diabetic

neuropathy market analyzes the current and future scenario of the global market. Increase in prevalence of diabetic neuropathy, advent of new therapeutics for treatment of neuropathy, favorable reimbursement scenario, and investment from key players
in development of cost effective therapeutics for diabetic neuropathy are the major drivers of the global diabetic neuropathy market.Read the full report: http://www.reportlinker.com/p05027981/Diabetic-Neuropathy-Market-Global-Industry-Analysis-Size-Share-Growth-Trends-and-Forecast.htmlThe diabetic neuropathy market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global diabetic neuropathy market with respect to the segments based on disorder type, treatment type, distribution channel and geography.A detailed qualitative analysis of drivers and restraints of the market and its opportunities has been provided in the market overview section. In addition, the section comprises Porter's five forces analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global diabetic neuropathy market.Global Diabetic Neuropathy Market: SegmentationBased on disorder type, the diabetic neuropathy market is segmented as peripheral neuropathy, autonomic neuropathy, proximal neuropathy, focal neuropathy. The disorder type market segments have been analyzed based on available approved treatment for disorders and patient data. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.Based on treatment type, diabetic neuropathy market is segmented into drugs, radiotherapy and physiotherapy. The drug segment is further segmented into analgesic, antidepressant, anticonvulsant drugs and other drugs. The analgesic segment is further segmented into topical, opioid, NSAIDs. The antidepressant segment is segmented into TCAs, SNRIs, and SSRIs. Radiotherapy segment is segmented into Transcutaneous Electrical Nerve Stimulation (TENS), others.The market segments have been extensively analyzed based on demand for available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.Global Diabetic Neuropathy Market: Regional AnalysisGeographically, the global diabetic neuropathy market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa).The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.Global Diabetic Neuropathy Market: Competitive AnalysisThe report also profiles major players in the global diabetic neuropathy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include – Johnson & Johnson (Janssen Global Services, LLC), Boehringer Ingelheim GmbH, NeuroMetrix, Inc., Eli Lilly and Company, GlaxoSmithKline plc, Pfizer, Inc., Lupin Limited, Astellas Pharma Inc., Glenmark Pharmaceuticals Ltd, Arbor Pharmaceuticals, LLC, Depomed, Inc., and others.The Global Diabetic Neuropathy Market is segmented as given below:Global Diabetic Neuropathy Market, by ProductPeripheral NeuropathyAutonomic NeuropathyProximal NeuropathyFocal NeuropathyGlobal Diabetic Neuropathy Market, by Treatment TypeDrugAnalgesicTopicalCapsaicinOthersOpioidsMorphineOthersNSAIDsIbuprofenNaproxenOthersAntidepressantTCAsAmitriptylineImipramineOthersSNRIsDuloxetineOthersSSRIsCitalopramParoxetinOthersAnticonvulsantsGabapentinPregabalinTopimarateOthersOther DrugsRadiotherapyTENSOthersPhysiotherapyGlobal Diabetic Neuropathy Market, by Distribution ChannelHospitalsClinicsRetail PharmacyOnline PharmacyGlobal Diabetic Neuropathy Market, by GeographyNorth AmericaUSCanadaEuropeGermanyU.K.RussiaItalyFranceSpainRest of EuropeAsia PacificJapanIndiaChinaAustralia & New ZealandRest of Asia PacificLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & AfricaGCC countriesSouth AfricaRead the full report: http://www.reportlinker.com/p05027981/Diabetic-Neuropathy-Market-Global-Industry-Analysis-Size-Share-Growth-Trends-and-Forecast.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com__________________________Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/diabetic-neuropathy-market---global-industry-analysis-size-share-growth-trends-and-forecast-2017---2025-300500633.html

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store